• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRELINK; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRELINK; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71926-01
Medical Device Problem Codes Unable to Obtain Readings (1516); Device Displays Incorrect Message (2591); Application Program Problem (2880)
Health Effect - Clinical Codes Hypoglycemia (1912); Cognitive Changes (2551)
Date of Event 12/23/2024
Type of Reportable Event Serious Injury
Event or Problem Description
An error message was reported with the abbott diabetes care (adc) device in use with an unknown phone with unknown operating system.The customer received a "replace sensor" message and was unable to obtain glucose readings.The customer experienced loss of reference points, imbalance, ¿less reflection¿ and was unable to self-treat, requiring third-party administration of yogurt and compote from a non-healthcare professional for treatment.There was no report of death or permanent impairment associated with this event.
 
Additional Manufacturer Narrative
Investigation is pending at this time.A follow up will be submitted once additional information is obtained.The operating system is unknown so product information provided is for ios.The device manufacturing date does not apply.The date entered in section h4 is the date abbott diabetes care became aware of the event.All pertinent information available to abbott diabetes care has been submitted.
 
Additional Manufacturer Narrative
Repeated attempts by adc to retrieve the product were unsuccessful and/or the customer discarded the product.The most probable root causes associated with this failure mode are disconnected, faulty or damaged components, software/data corruption, or misuse.However, mitigations are in place to reduce and prevent such issues.All vital manufacturing steps are validated, monitored, and verified during manufacturing to ensure the system is in conformance with the verified design.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.The most probable root causes associated with this failure mode are software/data corruption or misuse.However, mitigations are in place to reduce and prevent such issues.All vital functions are monitored by the system and, when necessary, function is suspended to safeguard against inaccurate results.Labeling is provided to instruct the user on the intended use of all vital parts of the system to minimize misuse.All complaints and complaint trends are investigated to determine if there is a product defect/ deficiency.If a product defect/ deficiency is identified, a risk evaluation is completed and compared to the risk management report, to ensure the risk profile has not changed.Additionally, as a part of abbott¿s post-market surveillance process, all risk evaluations with associated complaint data are reviewed annually to determine if the risk profiles have changed as compared to the product risk management reports.These monitoring processes ensure that all product risk profiles remain acceptable and have a positive benefit/ risk ratio.At this time, the product has not yet been returned for this complaint.An extended investigation has been performed for the reported complaint and there was no indication that the product did not meet specification.Dhrs (device history review) for the libre sensor and sensor kit was reviewed and the dhrs showed the libre sensor and sensor kit met specifications prior to release to distribution.The customer reported for replace sensor messages.The reported issue was investigated.Attempt to identify the customer's reported configurations and the information provided in the complaint was insufficient to conduct a comprehensive investigation.The lack of information regarding the app version and the operating system, it restricts the ability to identify potential causes of the customer's reported issue.If product is returned, a physical investigation will be performed per adc's established processes and procedures and a report will be submitted upon completion of investigation.All pertinent information available to abbott diabetes care has been submitted.
 
Event or Problem Description
An error message was reported with the abbott diabetes care (adc) device in use with an unknown phone with unknown operating system and with unknown app version.The customer received a "replace sensor" message and was unable to obtain glucose readings.The customer experienced loss of reference points, imbalance, ¿less reflection¿ and was unable to self-treat, requiring third-party administration of yogurt and compote from a non-healthcare professional for treatment.There was no report of death or permanent impairment associated with this event.
 
Additional Manufacturer Narrative
Sensor (b)(6) has been returned and investigated.The sensor plug is properly seated and no physical damage was observed on the sensor patch.Extracted data from the returned sensor using approved software.The sensor was found to be in sensor state 5 (indicating normal termination).Sensor state 5 with event logs 3 and 4 are an indication of normal termination of the sensor without any error.Visual inspection has been performed on the sensor plug assembly; no failure modes were observed.Sim vivo testing (simulation of the electrical signal produced by the sensor tail) and poise voltage testing were performed and all results were within specification.The passing of functionality testing is an indication that there were no issues with sensor functionality and electronics.Therefore, issue is not confirmed.This also serves as a correction report.Section d1 (brand name) was incorrectly submitted in the previous report.Correction has been made.All pertinent information available to abbott diabetes care has been submitted.
 
Event or Problem Description
An error message was reported with the abbott diabetes care (adc) device in use with an unknown phone with unknown operating system and with unknown app version.The customer received a "replace sensor" message and was unable to obtain glucose readings.The customer experienced loss of reference points, imbalance, ¿less reflection¿ and was unable to self-treat, requiring third-party administration of yogurt and compote from a non-healthcare professional for treatment.There was no report of death or permanent impairment associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRELINK
Common Device Name
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda 94502 7001
Manufacturer Contact
audra fuentes
1360 south loop road
alameda 94502-7001
5107495297
MDR Report Key21036410
Report Number2954323-2024-50604
Device Sequence Number12676519
Product Code QLG
UDI-Device Identifier00357599810009
UDI-Public00357599810009
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K201761
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date12/31/2025
Device Model Number71926-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/23/2024
Supplement Date Received by Manufacturer01/06/2025
02/08/2025
Initial Report FDA Received Date12/30/2024
Supplement Report FDA Received Date01/08/2025
02/11/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/04/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-